Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 5 Odds ratios for the primary end point (composite of cardiac end points), major cause-specific outcomes, and total mortality during the first three months of the VALUE trial after patients had been randomized to either valsartan or amlodipine monotherapy. Change in blood pressure ( BP) at three months refers to the lower mean blood pressures in patients randomized to amlodipine. Data are expressed as the odds ratios ± 95% confidence intervals (CI). Figure is adapted from data extracted from Julius et al. (9).
|
